EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Are we closer to achieving precision medicine for migraine treatment? A narrative review

Keiko Ihara, Francesco Casillo iD, Ahmed Dahshan, Hamit Genç iD, Asel Jusupova, Kunduz Karbozova, Wonwoo Lee iD, Yi Chia Liaw iD, Theodoros Mavridis iD, Hong-Kyun Park iD, Burcu Polat, Triin Helin Unt und 4 weitere

Cephalalgia · 2024-09 · 44 (9)

DOI: 10.1177/03331024241281518 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cephalalgia, online erschienen am 10.09.2024. Verfasst von Keiko Ihara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Migraine Disorders, Precision Medicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The term ‘precision medicine’ encompasses strategies to optimize diagnosis and outcome prediction and to tailor treatment for individual patients, in consideration of their unique characteristics. The greater availability of multifaceted datasets and strategies to model such data have made precision medicine increasingly possible in recent years. Precision medicine is especially needed in the migraine field since the response to migraine treatments is not universal amongst all individuals with migraine.

Objective

To provide a narrative review describing contributions to achieving precision medicine for migraine treatment.

Methods

A search of PubMed for English language articles of human participants published from 2005 to January 2024 was conducted to identify articles that reported research contributing to precision medicine for migraine treatment. The published literature was categorized and summarized according to the type of data that were included: clinical phenotypes, genomics, proteomics, physiologic measures, and brain imaging.

Results

Published studies have investigated characteristics associated with acute and preventive treatment responses, such as nonsteroidal anti-inflammatory drugs, triptans, onabotulinumtoxinA, and anti-calcitonin gene-related peptide monoclonal antibodies, in patients with episodic or chronic migraine. There is evidence that clinical, genetic, epigenetic, proteomic, physiologic, and brain imaging features might associate with migraine treatment outcomes, although inconsistencies for such findings clearly exist.

Conclusions

The published literature suggests that there are clinical and biological features which associate with, and might be useful for predicting, migraine treatment responses. To achieve precision medicine for migraine treatment, further research is needed that validates and expands on existing findings and tests the accuracy and value of migraine treatment prediction models in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersPrecision MedicineHumans

Stichwörter der Autor:innen

genomicsheadacheimagingmigrainepersonalized medicineprecision medicinepredictionproteomicstreatment

Autor:innen und Institutionen

  • Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
  • Neurology Department, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan.
  • Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino ICOT, Latina, Italy.
  • Department of Neurology, Cairo University, Cairo, Egypt.
  • Department of Neurology, Gaziantep City Hospital, Gaziantep, Türkiye.
  • Department of Neurology and Clinical Genetics, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan.

ORCID-Profile: Francesco Casillo, Hamit Genç, Wonwoo Lee, Yi Chia Liaw, Theodoros Mavridis, Hong-Kyun Park, Aisha Zhantleuova, Patricia Pozo-Rosich, Todd J Schwedt

Zitieren

APA

Ihara, K., Casillo, F., Dahshan, A., Genç, H., Jusupova, A., Karbozova, K., Lee, W., Liaw, Y. C., Mavridis, T., Park, H. K., Polat, B., Unt, T. H., Vashchenko, N., Zhantleuova, A., Pozo-Rosich, P., & Schwedt, T. J. (2024). Are we closer to achieving precision medicine for migraine treatment? A narrative review. Cephalalgia, 44(9). https://doi.org/10.1177/03331024241281518

Vancouver

Ihara K, Casillo F, Dahshan A, Genç H, Jusupova A, Karbozova K, et al. Are we closer to achieving precision medicine for migraine treatment? A narrative review. Cephalalgia. 2024;44(9). doi:10.1177/03331024241281518

BibTeX
@article{Ihara2024,
  author = {Ihara, Keiko and Casillo, Francesco and Dahshan, Ahmed and Genç, Hamit and Jusupova, Asel and Karbozova, Kunduz and Lee, Wonwoo and Liaw, Yi Chia and Mavridis, Theodoros and Park, Hong-Kyun and Polat, Burcu and Unt, Triin Helin and Vashchenko, Nina and Zhantleuova, Aisha and Pozo-Rosich, Patricia and Schwedt, Todd J},
  title = {Are we closer to achieving precision medicine for migraine treatment? A narrative review},
  journal = {Cephalalgia},
  year = {2024},
  volume = {44},
  number = {9},
  doi = {10.1177/03331024241281518}
}
Kostenlos starten →